The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTFB.L Share News (MTFB)

  • There is currently no data for MTFB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Shareholder Meetings Calendar - Next 7 Days

Wed, 23rd Sep 2020 16:13

Thursday 24 September 
Kainos Group PLCAGM
Alcentra European Floating Rate Income Fund LtdAGM
Securities Trust of ScotlandAGM
Sure Ventures PLCAGM
Triad Group PLCAGM
Versarien PLCAGM
Shearwater Group PLCAGM
Vertu Capital LtdAGM
Premier Veterinary Group PLCGM - acquisition and delisting
British & American Investment Trust PLCAGM
Caffyns PLCAGM
Miton Global Opportunities PLCAGM
Securities Trust of Scotland PLCAGM
Friday 25 September 
Schroder Real Estate Investment Trust LtdAGM
Star Phoenix Group LtdEGM re director removals
Catenae Innovation PLCAGM
ICG-Longbow Senior Secured UK Property Debt Investments LtdAGM
Marble Point Loan Financing PLCAGM
Fusion Antibodies PLCAGM
Solo Oil PLCAGM
Lekoil LtdAGM
Hydrogen Group PLCGM re delisting
Okyo Pharma LtdAGM
India Capital Growth Fund LtdAGM
Stagecoach Group PLCAGM
Monday 28 September 
Diageo PLCAGM
Time Out Group PLCAGM
Mulberry Group PLCAGM
Van Elle Holdings PLCAGM
Mereo BioPharma Group PLCAGM
Christie Group PLCAGM
Galileo Resources PLCAGM
Eddie Stobart Logistics PLCGM re financial statements
Challenger Acquisitions LtdAGM
Avon Rubber PLCGM re Team Wendy purchase
Tuesday 29 August 
PV Crystalox Solar PLCGM re tender offer
Raven Property Group LtdGM re tender offer
Novacyt SAAGM
Gama Aviation PLCAGM
Ince Group PLCAGM
IMImobile PLCAGM
Brickability Group PLCAGM
DCD Media PLCAGM
Jaywing PLCAGM
Carclo PLCAGM
Arcontech Group PLCAGM
Amigo Holdings PLCGM re Richmond Group resolutions
Rockfire Resources PLCGM re articles of association amendment
Appreciate Group PLCAGM
Augmentum Fintech PLCAGM
Wednesday 30 September 
Active Energy Group PLCAGM
Anglesey Mining PLCAGM
Catena Group PLCAGM
Chenvari Capital Solutions LtdEGM - re base currency change to euro
City of London Group PLCAGM
Clipper Logistics PLCAGM
Creightons PLCAGM
daVictus PLCAGM
Distribution Finance Capital Holdings PLCAGM
HML Holdings PLCAGM
IntegraFin Holdings PLCGM re hybrid general meetings
Marlowe PLCAGM
Mobile Tornado Group PLCAGM
Motif Bio PLCAGM
Powerhouse Energy Group PLCAGM
Purplebricks Group PLCAGM
Renishaw PLCAGM
San Leon Energy PLCAGM
Sosandar PLCAGM
Studio Retail Group PLCAGM
Tekmar Group PLCAGM
TheWorks.co.uk PLCAGM
Yew Grove REIT PLCEGM re gearing level
  
Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
17 Jul 2015 06:40

Motif Bio's Iclaprim Eligible For Incentives With New US Designation

Read more
23 Jun 2015 11:20

Motif Bio raises £22m via share placing

Biopharmaceutical company Motif Bio has raised £22m via a conditional share placing with institutional investors. The London-listed group said "the placing is conditional on securing shareholder approval and on a successful qualified infection disease product designation being given to its iclaprim

Read more
23 Jun 2015 09:28

Amphion Innovations Confident After Motif IPO, 2014 Asset Value Fall

Read more
23 Jun 2015 06:58

Motif Bio Raises GBP22 Million In Discounted Share Placing (ALLISS)

Read more
9 Jun 2015 08:27

Motif Bio Annual Loss Widened Slightly Ahead Of London IPO

Read more
1 Jun 2015 11:15

Motif Bio signs deal with leading clinical research organisation

A wholly-owned subsidiary of antibiotic developer Motif Bio has signed letters of intent and interim agreements with a leading global clinical research organisation (CRO). Motif has agreed to invest more than $0.95m under the agreements, which must be paid by the end of July. Under the agreements,

Read more
1 Jun 2015 07:23

Motif Bio Shares Up As It Moves Towards Iclaprim Clinical Trials

Read more
28 May 2015 09:47

Motif Bio Gets FDA Minutes Confirming Phase III Plans For Iclaprim

Read more
7 May 2015 09:12

Motif Bio Exploring Funding Options For Iclaprim Trials (ALLISS)

Read more
15 Apr 2015 07:31

LONDON MORNING BRIEFING: Next And Burberry Shares In Fashion

Read more
15 Apr 2015 07:10

Amphion Shares Up As Motif Bio Gets US FDA Approval For Iclaprim Trial

Read more
2 Apr 2015 11:46

Motif Bio makes AIM debut, seeks approval for Iclaprim treatment

Clinical stage biopharmaceutical group Motif Bio began trading on AIM on Thursday, after raising £2.8m in its initial public offering. The group, whose 44.09% of issued equity is owned by Amphion, placed shares at 20p each, said it had 64,238,442 ordinary shares in issue and a market capitalisation

Read more
2 Apr 2015 08:19

BCA Marketplace, Marshall Motor And Motif Bio Begin Trading (ALLIPO)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.